XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Operating expenses:        
Research and development $ 5,313,033 $ 1,380,801 $ 14,938,532 $ 5,594,886
General and administrative 2,361,299 1,472,969 7,403,817 3,022,244
Total operating expenses 7,674,332 2,853,770 22,342,349 8,617,130
Operating loss (7,674,332) (2,853,770) (22,342,349) (8,617,130)
Other income:        
Interest income 52,886 5,554 108,559 7,885
Grant income       36,754
Total other income 52,886 5,554 108,559 44,639
Net loss $ (7,621,446) $ (2,848,216) $ (22,233,790) $ (8,572,491)
Basic loss per common share $ (0.93) $ (0.35) $ (2.72) $ (1.15)
Diluted loss per common share $ (0.93) $ (0.35) $ (2.72) $ (1.15)
Weighted average number of common shares outstanding, basic 8,163,923 8,099,103 8,161,787 7,466,443
Weighted average number of common shares outstanding, diluted 8,163,923 8,099,103 8,161,787 7,466,443